Cargando…
The association of indoxyl sulfate with fibroblast growth factor‐23 in cats with chronic kidney disease
BACKGROUND: Indoxyl sulfate (IS) has been reported not only to increase with the severity of impaired renal function, but also possibly to be a factor associated with bone abnormalities linked to fibroblast growth factor‐23 (FGF‐23) in humans with chronic kidney disease (CKD). It is not yet known wh...
Autores principales: | Liao, Yu‐Lun, Chou, Chi‐Chung, Lee, Ya‐Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430881/ https://www.ncbi.nlm.nih.gov/pubmed/30779214 http://dx.doi.org/10.1111/jvim.15457 |
Ejemplares similares
-
The fecal microbiome and serum concentrations of indoxyl sulfate and p‐cresol sulfate in cats with chronic kidney disease
por: Summers, Stacie C., et al.
Publicado: (2018) -
Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p‐cresol sulfate
por: Summers, Stacie, et al.
Publicado: (2019) -
Relationship between Plasma Fibroblast Growth Factor‐23 Concentration and Survival Time in Cats with Chronic Kidney Disease
por: Geddes, R.F., et al.
Publicado: (2015) -
Fibroblast growth factor 23 and symmetric dimethylarginine concentrations in geriatric cats
por: Sargent, Hannah J., et al.
Publicado: (2019) -
Fibroblast Growth Factor‐23 Concentration in Dogs with Chronic Kidney Disease
por: Harjes, L.M., et al.
Publicado: (2017)